NEW YORK (GenomeWeb) – Quest Diagnostics today said that it plans to offer $1.2 billion in senior notes.

The Madison, NJ-based clinical lab firm said the offering is being made pursuant to a shelf registration filed with the US Securities and Exchange Commission. Goldman Sachs, JP Morgan Securities, Morgan Stanley, and Wells Fargo Securities will be the joint book-running managers for the offering.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.